期刊文献+

Non-alcoholic fatty liver disease and hepatocellular carcinoma:Clinical challenges of an intriguing link 被引量:1

下载PDF
导出
摘要 Non-alcoholic fatty liver disease(NAFLD)has emerged as the most common liver disorder worldwide mainly attributed to the epidemic spread of obesity and type 2 diabetes mellitus.Although it is considered a benign disease,NAFLD can progress to non-alcoholic steatohepatitis,liver cirrhosis and hepatocellular carcinoma(HCC).Most data regarding the epidemiology of NAFLD-related HCC are derived from cohort and population studies and show that its incidence is increasing as well as it is likely to emerge as the leading indication for liver transplantation,especially in the Western World.Although cirrhosis constitutes the main risk factor for HCC development,in patients with NAFLD,HCC can arise in the absence of cirrhosis,indicating specific carcinogenic molecular pathways.Since NAFLD as an underlying liver disease for HCC is often underdiagnosed due to lack of sufficient surveillance in this population,NAFLDHCC patients are at advanced HCC stage at the time of diagnosis making the management of those patients clinically challenging and affecting their prognostic outcomes.In this current review,we summarize the latest literature on the epidemiology,other than liver cirrhosis-pathogenesis,risk factors and prognosis of NAFLD-HCC patients.Finally,we emphasize the prevention of the development of NAFLD-associated HCC and we provide some insight into the open questions and issues regarding the appropriate surveillance policies for those patients.
出处 《World Journal of Gastroenterology》 SCIE CAS 2022年第3期310-331,共22页 世界胃肠病学杂志(英文版)
  • 相关文献

参考文献3

二级参考文献66

  • 1Xiao-Yan Duan, Liang Qiao and Jian-Gao Fan Department of Gastroenterology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, China ,Storr Liver Unit at the Westmead Millennium Institute, the University of Sydney at Westmead Hospital, Westmead, NSW 2145, Australia.Clinical features of nonalcoholic fatty liver disease-associated hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2012,11(1):18-27. 被引量:16
  • 2Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006, 295:1549-1555.
  • 3Musso G, Gambino R, Cassader M, Pagano G. Meta- analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severiW. Ann Med 2011, 43:617-649.
  • 4Ong JP, Younossi ZM. Nonalcoholic fatty liver disease (NAFLD)-two decades later: are we smarter about its natu- ral history? Am J Gastroentero12003, 98:1915-1917.
  • 5Adams LA, Sanderson S, Lindor KD, Angulo P. The histo- logical course of nonalcoholic fatty liver disease: a longitu- dinal study of 103 patients with sequential liver biopsies. J Hepato12005, 42:132-138.
  • 6Harrison SA, Torgerson S, Hayashi PH. The natural history of nonalcoholic fatty liver disease: a clinical histopathologi- cal study. Am J Gastroentero12003, 98:2042-2047.
  • 7Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steato- hepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003, 37:1202-1219.
  • 8Charlton M. Nonalcoholic fatty liver disease: a review of current understanding and future impact. Ctin Gastroenterol Hepato12004, 2:1048-1058.
  • 9Shimada M, Hashimoto E, Taniai M, Hasegawa K, Okuda H, Hayashi N, Takasaki K, Ludwig J. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol 2002, 37:154-160.
  • 10Davila JA, Morgan RO, Shaib Y, McGlynn KA, E1-Serag HB. Hepatitis C infection and the increasing incidence of hepato-cellular carcinoma: a population-based study. Gastroenterol- ogy 2004, 127:1372-1380.

共引文献33

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部